Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Manhattan Scientifics Signs Letter of Intent to Acquire Metallicum, Inc.

Abstract:
New Form of Metal Developed at the Los Alamos National Lab Holds Promise of Change for Dental Implants, Stents and Human Prosthetics

Manhattan Scientifics Signs Letter of Intent to Acquire Metallicum, Inc.

LOS ALAMOS, NM | Posted on March 31st, 2008

Manhattan Scientifics (Pink Sheets:MHTX) announced today that it has entered into a non-binding letter of intent (LOI) with Dr. Terry C. Lowe, president of Metallicum, Inc., to acquire Metallicum together with its patent rights to produce and market NanoTitanium and other ultra fine grain nano-structured metals.

The details of the planned merger were not disclosed. A definitive agreement is expected to be concluded within 60 days. Manhattan Scientifics plans to form a new Advanced Technologies division focusing on advanced science for advanced medicine.

These new ultra fine grain metals hold the promise for important advances in the medical device industry, particularly for dental implants, cardiovascular stents and for a wide range of prosthetic applications including artificial knees, shoulders, and hips. NanoTitanium is highly compatible with bone and is thought to provide stronger, faster bonding with improved strength, biocompatibility, longer life and improved wear and tear.

Founded in 2001, Metallicum has developed methods to modify the microstructure of metals by "nanostructuring" them. This procedure simultaneously increases the biocompatibility and strength of virtually any metal. For example, nanostructuring pure titanium (the material that is most commonly used in dental implants) can more than double its strength, making it stronger than most existing titanium alloys. The ability of bone cells to attach to nanostructured pure titanium surfaces at rates greater than 100% higher than with conventional alloys enables the development and marketing of a dental implant that can be fully integrated and useable with half the healing time of existing products. Other medical prosthetics will follow along the same path.

Manhattan Scientifics' newly elected CEO, Manny Tsoupanarias, added, "While we continue our efforts in the area of alternative energy and we have successfully incubated technologies associated with the U.S. Government labs in New Mexico, including Novint Technologies Inc. (OTCBB:NVNT), we have identified another promising opportunity. We have sufficient capital commitments to complete this acquisition and to fund its needs. We've opened discussions with potential customers in Europe and we are moving forward to conclude this transaction. We plan to manufacture the new metal in a plant already under construction in Albuquerque, NM and to generate profits by the sale of the metal and through licensing its use in medical prosthetics. Our goal is to build a profitable new business as we re-establish our strategic direction."

Dr. Terry Lowe, Metallicum's president, added, "Extensive trials of nanotitanium-based dental implants have been conducted in Europe over the past three years. Some 600 people have successfully used and demonstrated the advantages and safety of the new form of titanium we have developed. Given the excellent history in Europe, we plan to work with the FDA in the U.S. to apply for broad use of nanotitanium under FDA's section 510(k). Ultra fine grain metals are substantially equivalent to metals currently accepted for use in prosthetics for human beings, thus quick acceptance by the FDA is expected."

Lowe previously served as deputy director of the Materials Science and Technology division at the Los Alamos National Laboratory and was chiefly responsible for materials technology commercialization, overseeing up to 70 license, co-venture and other commercialization agreements per year.

Lowe was formerly CEO of Technanogy, the world's first and largest nanotechnology incubator. He led the company to its first commercial production and sales of aluminum nanoparticles.

####

About Manhattan Scientifics
Manhattan Scientifics, Inc., www.mhtx.com, is located in Montreal, Canada, New Mexico and New York City. It is developing and plans to acquire technologies in a variety of environmentally friendly energy and other people-friendly industries. Copies of Manhattan Scientifics’ press releases and related investor information may be found at www.hawkassociates.com and www.americanmicrocaps.com.

The foregoing press release contains forward-looking statements which are subject to risk and uncertainty which may be beyond the company’s control.

For more information, please click here

Contacts:
Manhattan Scientifics, Los Alamos
Manny Tsoupanarias, 514-917-2879

or
Dr. Terry Lowe, 505-670-8755

or
For Investor Relations:
Marvin Maslow, MHTX Chairman Emeritus, 917-923-3300

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Conductive Inks: booming to $2.8 billion by 2024 April 17th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Nanomedicine

Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Materials/Metamaterials

Thinnest feasible membrane produced April 17th, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Engineers develop new materials for hydrogen storage April 15th, 2014

Industrial Nanotech, Inc. Lands First Major Order from Pemex, Mexico’s State-Owned Oil and Gas Company April 14th, 2014

Announcements

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Acquisitions/Mergers/Splits

Applied Nanotech Holdings, Inc. (OTCQB: APNT) and Nanofilm, Ltd. Sign Merger Agreement March 14th, 2014

Harris & Harris Group Notes Molecular Imprints' Semiconductor Business To Be Acquired By Canon February 14th, 2014

FEI Buys Digital Rock Solutions Provider and microCT Product: Lithicon’s Solutions Will Expand FEI’s Oil & Gas Industry Offerings February 5th, 2014

World Mobile Holdings, Inc. Completes Order for Signage Media Player System and Announces the Merger Plan January 9th, 2014

Dental

Plasma tool for destroying cancer cells: Inducing biological tissue damage with an atmospheric pressure plasma source could open the door to many applications in medicine March 26th, 2014

Scientists develop world’s first light-activated antimicrobial surface that also works in the dark March 24th, 2014

Inhibition of oral biofilm and cell-cell communication using natural-products derivatives March 20th, 2014

Production of Water Insoluble Dental Adhesives in Iran March 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE